Stock Analysis·← Pickers

HTFL

HTFL is currently in a range/mixed trend, trading below both the 50-day and 200-day moving averages. RSI is at 42.9, with 1/3 trend checks passing.

Price
$27.25
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
42.9
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

HTFL with MA50 and MA200

39.9135.0530.2025.3420.4908/0810/3001/2704/2107/15
HTFL2025-08-082026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$29.93-8.97% vs price
MA200
$29.76-8.45% vs price
RSI (14)
42.9Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
$24.77–$25.755.5% below price · 3 touches
Support Quality
3 touches1.5× zone volume
Chart Summary
Trend summary for HTFL

HTFL currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $27.25, and 1 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 9.0% and below the 200-day moving average by 8.4%.

Momentum and stretch context

HTFL currently has an RSI reading of 42.9, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

This page is designed to help you quickly understand what the HTFL chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Heartflow, Inc. Common Stock

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
John Farquhar
Employees
843
Market cap
$2.35B
Beta
1.92
52-week range
$20.13 – $41.22
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
7 Aug 2025
ISIN
US42238D1072
CUSIP
42238D107
Company profile data from Financial Modeling Prep. HTFL listed on NASDAQ.
Share dilution

HTFL shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Mar 2024Mar 2026
Shares outstanding (latest)
368.5M
Since Mar 2024
+477.1%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. HTFL9 data points from Mar 2024 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about HTFL

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.